AbCellera Biologics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $4.09 on 07/07/25, while the lowest price for the same period was registered at $1.89 on 04/07/25.
52-week price history of ABCL Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. AbCellera Biologics Inc’s current trading price is -1.35% away from its 52-week high, while its distance from the 52-week low is 113.16%. The stock’s price range during the 52-week period has remained between $1.89 and $4.09. In the Healthcare sector, the company’s shares saw a trading volume of around 7.34 million for the day, which was evidently higher than the average daily volume of 5.4 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
AbCellera Biologics Inc (ABCL) has experienced a quarterly rise of 92.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.20B and boasts a workforce of 596 employees.
Making Sense of Trading Volume and Moving Average Data
Examining ABCL’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
ABCL Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 45.49% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 37.54%. Over the past 30 days, the price of ABCL has fallen by 66.53%. And in the last five days, it has surged by 11.63%.
